Core Viewpoint - Bailong Oriental (601339.SH) reported a decrease in institutional ownership in its A-shares, indicating a potential shift in investor sentiment [1] Institutional Ownership - As of August 14, 2025, five institutional investors disclosed holding a total of 702 million shares of Bailong Oriental, representing 46.82% of the company's total share capital [1] - The institutional ownership decreased by 4.22 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, Huatai-PB SSE Dividend ETF, reduced its holdings by 0.48% compared to the previous quarter [1] - Two public funds, Xingquan Business Model Mixed (LOF) A and Xingquan New Vision Periodic Open Mixed Initiated, were not disclosed in this period compared to the last quarter [1]

Group 1 - The core viewpoint of the news is that OrbiMed (688322.SH) has reported its annual results for 2024, highlighting significant institutional investor interest and changes in shareholding patterns [1] Group 2 - As of April 21, 2025, a total of 206 institutional investors disclosed holdings in OrbiMed A-shares, with a total shareholding of 127 million shares, accounting for 31.65% of the total share capital [1] - The top ten institutional investors include Shanghai Yunxin Venture Capital Co., Ltd., Zhuhai OrbiMed Investment Partnership (Limited Partnership), and others, with their combined shareholding ratio reaching 26.51% [1] - Compared to the previous quarter, the combined shareholding ratio of the top ten institutions decreased by 3.09 percentage points [1] Group 3 - In the public fund sector, four public funds reported a decrease in holdings compared to the previous quarter, including Bank of China Securities Advantage Manufacturing Stock A and others, with a slight decline in the proportion of reduced holdings [2] - A total of 193 new public funds were disclosed this period, including several funds such as Xingquan Helun Mixed A and others [2] - One public fund, Tianhong Guozheng 2000 Index Enhanced A, was not disclosed in this period compared to the previous quarter [2]

Group 1 - Bailong Oriental (601339.SH) released its 2024 annual report on April 16, 2025, indicating that as of April 15, 2025, 71 institutional investors disclosed holding shares, totaling 777 million shares, which accounts for 51.83% of the total share capital [1] - The top ten institutional investors collectively hold 51.66% of the shares, with a decrease of 2.96 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Huatai-PB SSE Dividend ETF, increased its holdings by 0.85% compared to the previous period [2] - Three public funds reduced their holdings, including Xingquan Business Model Mixed (LOF) A, Xingquan New Vision Regular Open Mixed, and Pengyang Jingze One-Year Holding Mixed A, with a total reduction of 2.20% [2] - A total of 63 new public funds were disclosed this period, including Huabai S&P China A-Share Dividend Opportunity ETF and Guotai Junan Blue Chip Value Mixed [2]

Group 1 - Blue Silicon Technology (300433.SZ) released its 2024 annual report on March 28, 2025, with 190 institutional investors holding a total of 3.804 billion shares, representing 76.34% of the total share capital [1] - The top ten institutional investors collectively hold 73.40% of the shares, with a slight decrease of 0.16 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings, accounting for a 0.26% increase, while six funds decreased their holdings, representing a 0.10% decrease [2] - A total of 14 new public funds were disclosed this period, while 123 funds were not disclosed compared to the previous quarter [2] - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 0.19% [2]

Group 1 - The core viewpoint of the news is that as of March 27, 2025, institutional investors hold a significant portion of Tiger Medical's A-shares, totaling 1.76 billion shares, which accounts for 20.31% of the company's total equity [1] - The top ten institutional investors collectively hold 14.86% of Tiger Medical's shares, with a decrease of 1.43 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings, while five funds decreased their holdings, with a total reduction rate of 0.19% [2] - A total of 16 new public funds were disclosed this period, including notable funds such as E Fund CSI 300 Medical ETF and others [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.30% compared to the previous quarter [2]